|本期目录/Table of Contents|

[1]张凯,胡文星,尹辉明,等.糖耐量减低的绝经后女性的和肽素水平对冠状动脉粥样硬化的影响[J].医学研究与战创伤救治(原医学研究生学报),2017,19(01):25-29.[doi:10.3969/j.issn.1672-271X.2017.01.007]
　ZHANG Kai,HU Wen-xing,YIN Hui-ming,et al.The impact of copeptin levels on coronary atherosclerotic lesions in postmenopausal women with impaired glucose tolerance[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(01):25-29.[doi:10.3969/j.issn.1672-271X.2017.01.007]
点击复制

糖耐量减低的绝经后女性的和肽素水平对冠状动脉粥样硬化的影响()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第19卷
期数:
2017年01期
页码:
25-29
栏目:
出版日期:
2017-01-20

文章信息/Info

Title:
The impact of copeptin levels on coronary atherosclerotic lesions in postmenopausal women with impaired glucose tolerance
作者:
张凯1; 胡文星2; 尹辉明3; 苑小历4; 卢新政5; 赵仙先6
1. 200001上海，第二军医大学长海医院心内科（医学博士研究生，现在南京医科大学附属邵逸夫医院心内科工作）；2. 210002南京，第二军医大学金陵医院（南京军区南京总医院）皮肤科；3.418000怀化，怀化医学高等专科学校附属怀化市第三人民医院呼吸科；4. 210002南京，第二军医大学金陵医院（南京军区南京总医院）干部保健科；5. 210000南京，南京医科大学附属邵逸夫医院心内科；6. 200001上海，第二军医大学长海医院心内科
Author(s):
ZHANG Kai1; HU Wen-xing2; YIN Hui-ming3; YUAN Xiao-li4; LU Xin-zheng 5; ZHAO Xian-xian6
1．Department of Cardiology，Changhai Hospital of Second Military Medical University，Shanghai 200001，China；Department of Cardiology，Sir Run Run Hospital affiliated to Nanjing Medical University，Nanjing 210000，Jiangsu，China；2．Department of Dermatology，Nanjing Clinical Medical College of Second Military Medical University/Nanjing General Hospital of Nanjing Military Region, PLA,Nanjing 210002，Jiangsu，China；
关键词:
和肽素; 精氨酸血管加压素; 糖耐量减低; 绝经期; 女性; 冠状动脉粥样硬化
Keywords:
Copeptin;  arginine vasopressin(AVP);  Impaired glucose tolerance(IGT);  Menopause;  female;  Coronary atherosclerosis
分类号:
R587.1
DOI:
10.3969/j.issn.1672-271X.2017.01.007
文献标志码:
A
摘要:
目的 观察糖耐量减低的绝经后女性基线血浆和肽素（copeptin）水平对冠状动脉粥样硬化病变发生、发展的影响。方法 新发糖耐量减低（空腹血糖≤6.2 mmol/L，7.8 mmol/L≤早餐后2 h血糖≤9.4 mmol/L）的绝经后女性（年龄在56~59岁之间）共80例，依据基线时copeptin水平，分成对照组（＜5 pmol/L）、高和肽素组（＞20 pmol/L），每组各40例。分析两组间基线时和3个月后冠状动脉CTA狭窄程度积分的差异。结果 ①基线时，两组间的copeptin差异有统计学意义（P＜0.05），而在体重、空腹全血血糖、早餐后2 h血糖、空腹血清三酰甘油、血清总胆固醇、血清低密度脂蛋白胆固醇、平均动脉压、血清肌酐水平、年龄等指标上两组结果 相似，差异无统计学意义（P＞0.05）。②予以调整生活方式及口服阿司匹林（100 mg qd）、瑞舒伐他汀（10 mg qd）3个月后，在copeptin水平、冠状动脉CTA的狭窄程度积分、早餐后2 h血糖指标上，高和肽素组明显高于对照组，差异有统计学差异（P＜0.05），且高和肽素组有冠心病的发病，对照组没有。结论 在糖耐量减低、绝经后女性的冠心病危险因素的基础上，高血浆copeptin水平会进一步促进冠状动脉粥样硬化病变发生和恶化。
Abstract:
Objective To observe the impact of copeptin levels on coronary atherosclerotic lesions in postmenopausal women with impaired glucose tolerance (IGT).Methods 80 postmenopausal women (aged 56-59 years) with the onset of IGT (fasting blood glucose，i.e. FBG ≤6.2 mmol/L, 7.8 mmol/L≤2-hour postprandial blood glucose，i.e.2hPBG≤9.4 mmol/L) were divided into control group (copeptin<5 pmol/L) and high-copeptin group (copeptin > 20 pmol/L), according to serum copeptin levels at baseline, 40 cases in each group. The discrepancy of coronary CTA stenosis scores were analyzed between the two groups at baseline and after 3-months follow-up.Results ①At baseline, the difference was statistically significant in copeptin levels (P<0.05), but not in weight, FBG, 2hPBG, fasting serum triglyceride (TG), total serum cholesterol(TC), serum low-density lipoprotein cholesterol(LDL-C), mean arterial pressure, serum creatinine and age between the two groups (P>0.05). ②After 3-months therapeutic lifestyle adjustment as well as oral administration of aspirin (100 mg qd) and rosuvastain (10 mg qd), copeptin level, coronary CTA stenosis scores, and 2hPBG of high-copeptin group were statistically significantly higher compared with control group respectively(P<0.05). Furthermore, some cases developed coronary heart disease (CHD) in high-copeptin group, while not in control group.Conclusion On the basis of the influence of the atherosclerotic risk factors of IGT and postmenopausal female, high plasma copeptin level will further promote the occurrence and deterioration of coronary atherosclerotic lesions.

参考文献/References:

[1]Sukul D,Marc P,Christian T,et al.Diagnostic performance of copeptin in patients with acute nontraumatic chest pain: BWH-TIMI ED Chest Pain Study[J]. Clin Cardiol,2014,37(4):227-232．
[2]Günebakmaz O,Celik A,Inanc NT,et al.Copeptin level and copeptin response to percutaneous balloon mitral valvuloplasty in mitral stenosis[J]. Cardiology, 2011,120(4):211-216.
[3]Enhrning S，Wang TJ, Nilsson PM，et al．Plasma Copeptin and the Risk of Diabetes Mellitus[J]. Circulation，2010，121(19)：2102-2108．
[4]Hernandez RD, Garca SJM, Lopez CA,et al．High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS[J]. Sci World J，2012（2）:578616. doi: 10.1100/2012/578616.
[5]Mizia SK，Lasota B，Magdalena M，et al. Copeptin constitutes a novel biomarker of degenerative aortic stenosis[J]. Heart Vessels,2013，28(5):613-619.
[6]Solymoss BC，Bourassa MC，Lesperance J，et al．Incidence and characteristics of the metabolic syndrome in patient with coronary artery disease[J]. Coron Artery Dis，2003，14：207-212.
[7]Reichlin T，Hochholzer W，Stelzig C,et al.Incremental value of copeptin for rapid rule out of acute myocardial infarction[J]．J Am Coll Cardiol，2009，54(1): 60-68.
[8]Morgenthaler NG.Copeptin:a biomarker of cardiovascular and renal function[J]．Congest Heart Fail,2010,16(Suppl 1):S37.
[9]Khan SQ，Dhillon OS，Quinn PA，et al． C-terminal provasopressin (copeptin)as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study[J]. Circulation，2007，115(16): 2103-2110.
[10]Dieplinger B,Gegenhuber A,Haltmayer M,et al.Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath[J]. Heart,2009,95(18):1508-1513.
[11]Ede H, Karaavu �瘙 塂 S,Gmen AY，et al.Serum copeptin level can be a helpful biomarker in evaluation of myocardial perfusion scintigraphy results[J]. Cardiol J, 2016, 23(1): 71-77.
[12]王晓艳，杨侃，孙明，等.脑钠肽及和肽素水平与冠心病患者冠脉病变程度的相关性[J]. 中国全科医学杂志，2010，13（2）：145-147.
[13]Morgenthaler NG,Struck J,Jochberger S,et al.Copeptin:clinical use of a new biomarker［J］.Trends Endocinol Metab,2008,19(2):43-49.
[14]肖洋，张志刚，柴三葆，等．多种疾病患者血浆copeptin测定[J]．放射免疫学杂志，2008,21(2):97-100.
[15]王晓艳，杨侃，孙明，等.脑钠肽、和肽素和高敏C反应蛋白与急性冠脉综合征的相关性[J]. 中国动脉硬化杂志，2009，17（2）：229-231.
[16]Voors AA，von Haehling S，Anker SD，et al.C-terminal provasopressin（copeptin）is a strong prognosic marker in patients with heart failure after an acute myocardial infarction：results from the OPTIMAAL study[J]. Eur Heart J,2009，30：1187-1194

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2017-01-20